Taking Unparalleled Results to Treat the Next Epidemic
Since donning its new corporate identity earlier this year, Algernon …
Novartis buys NASH biotech IFM Tre in potential $1.575 billion deal
Novartis is to buy US biotech IFM Tre, adding a potential drug for …
Biotechnology Companies Ramp up Funding as Deadly Diseases Come Into the Spotlight
News commentary on marketwatch.com about Algernon Pharmaceuticals. …